Bone Tumor Ablation Devices Market to Cross US$ 111.1 Million at a CAGR of 10.2% by 2030 | Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc.

Bone Tumor Ablation Devices Market Analysis

Bone Tumor Ablation Devices Market, by Indication (Chondrosarcoma, Metastatic Bone Cancer, Osteosarcoma, Ewing’s Sarcoma, and Others), by Technology (Microwave Ablation, Cryoablation, Radiofrequency Ablation, and Others), by End User (Ambulatory Surgical Centers, Specialty Clinics, and Hospitals), and by Region (Africa, Latin America, Asia Pacific, North America, Europe, and the Middle East) – Share, Outlook, Size, and Opportunity Analysis, 2020 – 2027

When cells within a bone divide uncontrollably, a lump or mass of abnormal tissue forms, which is known as a bone tumor. Most of these tumors are benign and not cancerous. They usually do not pose a threat to life, and they don’t spread to other parts of the body. The treatment for these tumors varies depending on the type, ranging from clinical observation to surgical removal. As people age, their bone health tends to deteriorate, increasing the likelihood of accidents and fractures. In 2014, the National Osteoporosis Foundation reported that over half of the U.S. adult population in 2013 was affected by bone disorders, with 10.2 mn adults having osteoporosis and another 43.4 mn having low bone mass.

There are various ablation techniques that can be utilized for the treatment of bone tumors. These techniques have numerous benefits, including minimal invasiveness, precise targeting of the tumor, and a low incidence of complications. Radiofrequency Thermal Ablation (RFTA) and Cryosurgery are currently the most commonly used techniques in this regard.

Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4319

Impact of the COVID-19 Pandemic:

In most cases of bone tumors, either for a cure or to manage painful bone metastases, bone tumor ablation surgery is necessary. With the onset of the COVID-19 pandemic, surgeries, immunotherapy, and chemotherapy for cancer patients are frequently delayed or cancelled. However, during this time, bone tumor ablation surgery is increasingly becoming the preferred treatment option because it is minimally invasive, requires less time, and is cost-efficient. In 2014, NCBI released data indicating that ablation of bone tumors in patients with painful metastatic bone disease is a safe treatment method that can alleviate pain and enhance the quality of life of cancer patients. However, delivering care for patients with bone cancer during the current crisis is a complex task, as there is a risk of death due to cancer as well as from SARS-CoV-2. Immune-compromised individuals are more susceptible to COVID-19, which further increases the challenge of providing adequate care for patients.

According to estimates, the market for devices used for bone tumor ablation was worth US$ 56.2 mn in 2020, and it is projected to grow at a compound annual growth rate (CAGR) of 10.2% between 2020 and 2027.

The market for bone tumor ablation devices is anticipated to experience growth due to the rising number of product launches in this field.

Major contributors to the industry are engaged in creating innovative devices for ablation of bone tumors and introducing them to the market. The introduction of these sophisticated systems is predicted to greatly boost the growth of the market and foster a favorable atmosphere for the bone tumor ablation devices market during the projected time frame. Medtronic Plc., for example, unveiled the OsteoCool RF Ablation System in January 2016 to manage spinal metastases. This system allows for the treatment of painful bone tumors with the simultaneous use of two probes. Additionally, the OsteoCool RF Ablation System was introduced in Canada in 2017 by Medtronic plc, specifically for treating bone metastases. In 2015, DFINE, Inc. also launched the Long SpineSTAR ablation instrument, which is the sole radiofrequency device that is both steerable and navigational in the market and is intended for the palliative therapy of metastatic spine tumors.

The market for bone tumor ablation devices is poised for growth due to the rising incidence of bone cancer, which presents lucrative opportunities. In the U.S., the American Cancer Society reported approximately 3,300 novel cases of bone cancer and 1,490 related deaths in 2016. Furthermore, chondrosarcomas, a type of primary bone cancer, account for more than 40% of cases in adults, according to the ACS.

Restraints:

The growth of the bone tumor ablation devices market is likely to be impeded by a significant factor: the limited understanding of bone tumor ablation surgery’s advanced therapies and new technologies among both patients and healthcare professionals. In developing countries like Africa and the Asia Pacific, rural areas, in particular, have inadequate knowledge of these novel technologies. Consequently, the slow adoption of bone tumor ablation devices in these regions is anticipated to hinder the market’s growth. During the projected period, the global bone tumor ablation market is expected to face hindrances due to several factors, such as the scarcity of skilled surgery professionals in certain regions, the limited lifespan of bone tumor ablation devices, and the extended approval time required for product launch.

Regional Analysis:

The global market for bone tumor ablation devices is categorized by geographical region, including Africa, Latin America, Asia Pacific, North America, Europe, and the Middle East.

During the forecast period, the bone tumor ablation devices market is projected to experience the highest profitability in North America, primarily due to the increasing incidence of osteosarcoma. Osteosarcoma, the most prevalent form of bone cancer, frequently affects children and young adults and is categorized as high-, intermediate-, or low-grade based on cells. According to the American Cancer Society, approximately 800 to 900 fresh cases of osteosarcoma are detected annually in the United States, with around half of these affecting youngsters and teenagers. This trend is expected to fuel the expansion of the bone tumor ablation devices market in the North American region.

Technological advancements in minimally invasive treatment therapies are anticipated to drive the growth of bone tumor ablation devices in the Asia-Pacific region. Additionally, ongoing conferences regarding the use of ablation technology in the region are anticipated to raise awareness among healthcare providers. For example, in 2019, Chang Gung Memorial Hospital in Taiwan hosted ACTA 2019, an Asian Conference of Tumor Ablation, which centered on the principles and technical aspects of various ablation techniques such as microwave ablation (MW), radiofrequency ablation (RFA), irreversible electroporation (IRE), cryoablation, and numerous guiding techniques, including imaging fusion.

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4319

Prominent players:

Prominent participants, including RF Medical Co., Ltd., Medtronic Plc., Misomix Inc., Merit Medical Systems Inc., Varian Medical Systems Inc., MedWaves Inc., Olympus Corporation, Mermaid Medical A/S, and AngioDynamics Inc., are operating in the global bone tumor ablation devices market.

Table of Contents with Major Points:

Executive Summary

• Introduction
• Key Findings
• Recommendations
• Definitions and Assumptions

Market Overview

• Definition of Bone Tumor Ablation Devices Market
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Trends and Developments

Key Insights

• Key Emerging Trends
• Key Developments Mergers and Acquisition
• New Product Launches and Collaboration
• Partnership and Joint Venture
• Latest Technological Advancements
• Insights on Regulatory Scenario
• Porters Five Forces Analysis

Qualitative Insights Impact of COVID-19 on Global Bone Tumor Ablation Devices Market

• Supply Chain Challenges
• Steps taken by Government/Companies to overcome this impact
• Potential opportunities due to COVID-19 outbreak

Conclusion 

Appendix

• Data Sources
• Abbreviations
• Disclaimer

TOC Continued…!

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/insight/buy-now/4319

Why Choose Coherent Market Insights?

☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services.

☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising.

☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers.

Explore More Related Insights:

Muscle stimulation devices market

Radial compression devices market

Medical devices reimbursement market

Medical device cleaning market